Subject area |
Gastrointestinal inflammation |
More specific subject area |
Colitis, gut inflammation, intestinal microbiome, biological signature |
Type of data |
Figures |
How data was acquired |
LC/TOF-MS and GC/TOF-MS |
Data format |
Analyzed |
Experimental factors |
Ginsenoside compound K was determined in mouse fecal samples with or without metronidazole treatment. Fecal metabolomic profiles of DSS mice and ginseng treated DSS mice were investigated. |
Experimental features |
Metabolomic fecal profiling from DSS model group and ginseng treated group |
Data source location |
Data was collected at University of Chicago, Chicago, IL, USA |
Data accessibility |
Data is provided within this article |
Related research article |
C.Z. Wang, H. Yao, C.F. Zhang, L. Chen, J.Y. Wan, W.H. Huang, et al., American ginseng microbial metabolites attenuate DSS-induced colitis and abdominal pain, Int. Immunopharmacol. 64 (2018) 246–251.[1](DOI:10.1016/j.intimp.2018.09.005)
|